CHEBI:2896 - astemizole

ChEBI IDCHEBI:2896
ChEBI Nameastemizole
Stars
DefinitionA piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
Last Modified23 April 2020
DownloadsMolfile
FormulaC28H31FN4O
Net Charge0
Average Mass458.581
Monoisotopic Mass458.24819
SMILESCOc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
InChIInChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)
InChIKeyGXDALQBWZGODGZ-UHFFFAOYSA-N
Roles Classification
Biological Roles:
H1-receptor antagonist  H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
anticoronaviral agent  Any antiviral agent which inhibits the activity of coronaviruses.
Applications:
H1-receptor antagonist  H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
anti-allergic agent  A drug used to treat allergic reactions.
ChEBI Ontology
Outgoing Relation(s)
astemizole (CHEBI:2896) has role anti-allergic agent (CHEBI:50857)
astemizole (CHEBI:2896) has role anticoronaviral agent (CHEBI:149553)
astemizole (CHEBI:2896) has role H1-receptor antagonist (CHEBI:37955)
astemizole (CHEBI:2896) is a benzimidazoles (CHEBI:22715)
astemizole (CHEBI:2896) is a piperidines (CHEBI:26151)
IUPAC Name 
1-(4-fluorobenzyl)-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-amine
INNs  Source
astemizolChemIDplus
astemizoleKEGG DRUG
astemizolumChemIDplus
Synonyms  Source
1-(p-Fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazoleChemIDplus
1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazoleChemIDplus
AstemisonChemIDplus
GNF-Pf-2461ChEMBL
NSC-329963ChEMBL
NSC-759570ChEMBL
Brand Name  Source
Pollon-ezeChEMBL
Manual XrefsDatabases
249DrugCentral
C06832KEGG COMPOUND
D00234KEGG DRUG
DB00637DrugBank
EP5318Patent
LSM-5502LINCS
US4219559Patent
Registry NumbersSources
Beilstein:4830190Beilstein
CAS:68844-77-9ChemIDplus
CAS:68844-77-9DrugBank
CAS:68844-77-9KEGG DRUG
CAS:68844-77-9KEGG COMPOUND
Citations